Arthur J. Higgins, President and CEO at DEPOMED INC (DEPO), bought 75,000 shares at $8.16 ($612K) on 2017-12-14, disclosed to the SEC on 2017-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ECL | SELL | 2024-05-08 | $1.0M | — | Filing → |
| ZBH | BUY | 2023-08-25 | $116K | — | Filing → |
| ECL | SELL | 2023-06-15 | $870K | — | Filing → |